Light PharmaLightPharma
Top-5 Pharma ManufacturerRegulatory Readiness

Mock FDA Inspection & Compliance Risk Mitigation for Critical Site

0
Critical findings at FDA inspection
Clean inspection outcome
28
Risks identified & mitigated
Before actual inspection
12 wks
Assessment to inspection-ready
Compressed timeline
15+
Observations prevented
Based on gap remediation

The Challenge

With a major FDA inspection imminent, a top-5 pharmaceutical manufacturer engaged Light Pharma to conduct a rigorous mock inspection and develop a prioritized risk mitigation plan. The site had not been inspected in 4 years and had undergone significant changes.

Our Solution

Light Pharma's team of ex-FDA inspectors identified critical gaps and managed the remediation program through to completion, ensuring the site was inspection-ready within a compressed timeline.

Our Approach

1

Pre-inspection document review and gap analysis

2

On-site mock inspection by ex-FDA investigators

3

Risk prioritization based on comparable site histories

4

Project management of remediation activities through completion

Results

0
Critical findings at FDA inspection
Clean inspection outcome
28
Risks identified & mitigated
Before actual inspection
12 wks
Assessment to inspection-ready
Compressed timeline
15+
Observations prevented
Based on gap remediation

Ready to Achieve Similar Results?

Let's discuss how Light Pharma can help you solve your quality and compliance challenges.